Journal of Multiple Sclerosis and Neuroimmunology

Review Article

June 30, 2024

Clinicoradiological Factors for Predicting and Monitoring the Progression of Multiple Sclerosis

Jiwon Yang

J Mult Scler Neuroimmunol. 2024;15(1):1-6.

As knowledge of pathophysiology and treatment options for multiple sclerosis has been expanding, decisions about when and which drugs we should start and switch appropriately have became important. It should...

Review Article

June 30, 2024

Imaging Biomarkers for Differential Diagnosis of Central Nervous System Inflammatory Diseases

Soonwook Kwon

J Mult Scler Neuroimmunol. 2024;15(1):7-16.

Inflammatory diseases of the central nervous system (CNS) include multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), and acute disseminated encephalomyelitis. In addition, various...

Review Article

June 30, 2024

Monoclonal Antibody Treatment for Relapse Prevention in Neuromyelitis Optica Spectrum Disorder

Jae-Won Hyun

J Mult Scler Neuroimmunol. 2024;15(1):17-22.

Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory disease of the central nervous system that can lead to devastating neurological disabilities such as blindness and impaired mobility. Given that NMOSD...

Review Article

June 30, 2024

Autoimmune Nodopathy: When to Suspect and How to Treat?

Young Gi Min, Ha Young Shin, Jung-Joon Sung

J Mult Scler Neuroimmunol. 2024;15(1):23-30.

Autoimmune nodopathy (AN) is a rare condition marked by autoantibodies that target specific proteins located within the node of Ranvier or paranodes. This disorder is distinctly different from chronic inflammatory...

Case Report

June 30, 2024

Severe Neutropenia Following Rituximab Treatment in Patients with Multiple Sclerosis

Ki Hoon Kim, Su-Hyun Kim, Jae-Won Hyun, et al.

J Mult Scler Neuroimmunol. 2024;15(1):31-34.

Increasing evidence suggests that B cells play a critical role in the pathogenesis of multiple sclerosis (MS). Rituximab (RTX), a monoclonal anti-CD20 antibody, effectively decreases inflammatory disease processes in patients...

Case Report

June 30, 2024

Emotional Incontinence in a Patient with Neuromyelitis Optica Spectrum Disorder

Suk-Won Ahn

J Mult Scler Neuroimmunol. 2024;15(1):35-39.

The pathologic laughing is involuntary and associated with brain damage seen in a variety of disorders, which occurs as a result of lesions in various locations and is often seen...

Neuroimage

June 30, 2024

An Immunoglobulin G4-Related Hypertrophic Pachymeningitis Involving Cerebral Parenchyma

Ki Hoon Kim, Su-Hyun Kim, Jae-Won Hyun, et al.

J Mult Scler Neuroimmunol. 2024;15(1):40-41.

Current Issue: Volume 15(1); Jun 2024

Multiple Sclerosis in Korea: A Hospital-Based, Multicenter, Epidemiological Study

Su-Hyun Kim, Eun-Jae Lee, Ju-Hong Min, et al.

J Mult Scler Neuroimmunol. 2023;14(1):51-55.

Cited By 2

Original Article

Jun 30, 2023

Journal of Multiple
Sclerosis and
Neuroimmunology

Print ISSN: 2733-8290
Online ISSN: 2951-2972

MOST VIEWED MOST CITED

6,005	Understanding MRI Features of Multiple Sclerosis: Based on the 2017 McDonald Criteria
2,660	Rituximab Treatment for Neuroimmunologic Disorders
2,349	National Consensus Guidance for the Diagnosis and Management of Adult Patients with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
2,323	Multiple Sclerosis in Korea: A Hospital-Based, Multicenter, Epidemiological Study
2,214	Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Review

+more

Cited By
2

Multiple Sclerosis in Korea: A Hospital-Based, Multicenter, Epidemiological Study

+more

Editorial Office: Department of Neurology, Chung-Ang University Hospital, Chung-Ang University College of Medicine 102, Heukseok-ro, Dongjak-gu, Seoul 06973, Korea
Tel: +82-2-6299-3153 E-mail: icandr@cau.ac.kr